Structurally Simple Inhibitors of Lanosterol 14α-Demethylase Are Efficacious In a Rodent Model of Acute Chagas Disease
摘要:
We report structure-activity studies of a large number of dialkyl imidazoles as inhibitors of Trypanosoma cruzi lanosterol-14 alpha-demethylase (L14DM). The compounds have a simple structure compared to posaconazole, another L14DM inhibitor that is an anti-Chagas drug candidate. Several compounds display potency for killing T cruzi amastigotes in vitro with values of EC50 in the 0.4-10 nM range. Two compounds were selected for efficacy studies in a mouse model of acute Chagas disease. At oral doses of 20-50 mg/kg given after establishment of parasite infection, the compounds reduced parasitemia in the blood to undetectable levels, and analysis of remaining parasites by PCR revealed a lack of parasites in the majority of animals. These dialkyl imidazoles are substantially less expensive to produce than posaconazole and are appropriate for further development toward an anti-Chagas disease clinical candidate.
Structurally Simple Inhibitors of Lanosterol 14α-Demethylase Are Efficacious In a Rodent Model of Acute Chagas Disease
摘要:
We report structure-activity studies of a large number of dialkyl imidazoles as inhibitors of Trypanosoma cruzi lanosterol-14 alpha-demethylase (L14DM). The compounds have a simple structure compared to posaconazole, another L14DM inhibitor that is an anti-Chagas drug candidate. Several compounds display potency for killing T cruzi amastigotes in vitro with values of EC50 in the 0.4-10 nM range. Two compounds were selected for efficacy studies in a mouse model of acute Chagas disease. At oral doses of 20-50 mg/kg given after establishment of parasite infection, the compounds reduced parasitemia in the blood to undetectable levels, and analysis of remaining parasites by PCR revealed a lack of parasites in the majority of animals. These dialkyl imidazoles are substantially less expensive to produce than posaconazole and are appropriate for further development toward an anti-Chagas disease clinical candidate.
Pd/Cu-Catalyzed aerobic oxidative aromatic C–H bond activation/N-dealkylative carbonylation towards the synthesis of phenanthridinones
作者:Renyi Shi、Huiying Niu、Lijun Lu、Aiwen Lei
DOI:10.1039/c6cc08701a
日期:——
A straightforward Pd/Cu-catalyzed oxidative C–H bond activation/N-dealkylative carbonylation of tertiary [1,1′-biphenyl]-2-anilines towards the synthesis of various biologically important phenanthridin-6(5H)-ones has been developed. A wide range of functional groups are well tolerated in this transformation.
2,5-DIAMINO-1-PHENYLBENZOL-DERIVATE ENTHALTENDE OXIDATIONSHAARFÄRBEMITTEL SOWIE NEUE 2,5-DIAMINO-1-PHENYLBENZOL-DERIVATE
申请人:Wella Aktiengesellschaft
公开号:EP1051143B1
公开(公告)日:2004-07-21
US6500213B1
申请人:——
公开号:US6500213B1
公开(公告)日:2002-12-31
[DE] 2,5-DIAMINO-1-PHENYLBENZOL-DERIVATE ENTHALTENDE OXIDATIONSHAARFÄRBEMITTEL SOWIE NEUE 2,5-DIAMINO-1-PHENYLBENZOL-DERIVATE<br/>[EN] OXIDIZING HAIR COLORING AGENTS CONTAINING 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES AND NOVEL 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES<br/>[FR] PRODUITS DE COLORATION OXYDANTE POUR LES CHEVEUX CONTENANT DES DERIVES DE 2,5-DIAMINO-1-PHENYLBENZOL ET NOUVEAUX DERIVES DE 2,5-DIAMINO-1-PHENYLBENZOL
申请人:——
公开号:WO1999059527A2
公开(公告)日:1999-11-25
[EN] The invention relates to oxidizing agents for coloration of keratin fibers, especially hair, based on a combination of developer-coupler substances, characterized in that they contain at least one 2,5-diamino-1-phenylbenzene derivative of general formula (I) as a developer substance. The invention also relates to novel 2,5-diamino-1-phenylbenzene derivatives according to formula (I), wherein at least one of the radicals R1-R10 is different from hydrogen. [FR] L'invention concerne des produits de coloration oxydante de fibres kératiniques, notamment de cheveux, à base d'une association substance copulatrice/substance révélatrice. Ces produits sont caractérisés en ce qu'ils contiennent comme substance révélatrice au moins un dérivé de 2,5-diamino-1-phénylbenzol de la formule générale (I). L'invention concerne également de nouveaux dérivés 2-5-diamino-1-phénylbenzol selon la formule (I), dans lesquels au moins un des restes R1 à R10 n'est pas de l'hydrogène. [DE] Gegenstand der vorliegenden Anmeldung sind Mittel zur oxidativen Färbung von Keratinfasern, insbesondere Haaren auf der Basis einer Entwicklersubstanz-Kupplersubstanz-Kombination, welche dadurch gekennzeichnet sind, dass sie als Entwicklersubstanz mindestens ein 2,5-Diamino-1-phenylbenzol-Derivat der allgemeinen Formel (I) enthalten, sowie neue 2,5-Diamino-1-phenylbenzol-Derivate gemäss Formel (I), in denen mindestens einer der Reste R1 bis R10 von Wasserstoff verschieden ist.